Clinical Trial

Adjuvant Chemotherapy for BTC Based on 3D-PTA

Name: Adjuvant Chemotherapy for BTC Based on 3D-PTA — clinical trial record (NCT07296666)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a prospective, open-label, controlled, multicenter clinical study designed to observe and evaluate the efficacy and safety of chemotherapy (including capecitabine monotherapy) guided by 3D-PTA drug sensitivity testing versus capecitabine monotherapy as adjuvant treatment in patients with stage II/III cholangiocarcinoma after surgery.

Trial Details

NCT Number	NCT07296666
Lead Sponsor	Fudan University
Conditions	Cholangiocarcinoma
Enrollment	98 participants
Start Date	2025-12
Primary Completion	2027-10 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2025-12-22